Prognostische Bedeutung des p53/Bax/p16INK4a-Signalwegs bei Patienten mit kolorektalem KarzinomKatharina Schelwies 3417248#40381.11.1.19101.1.21.211121.3131.414151.51.5.11.5.1.1161.5.1.2171.5.2181.6191.6.120622#4342122231.6.224624#379251.6.32627364#415281.6.4291.6.4.130311.6.4.2321.6.4.333341.72352.1362.22.2.1372.2.22.2.338392.2.440412.2.542432.2.6442.2.7452.32.3.1462.3.22.3.3472.3.3.12.3.4482.3.52.3.63493.1408#324503.2586#2953.351512#20152622#451533.4528#20554606#4925556623#4953.557623#1813.63.6.1528#233583.6.2624#2523.6.359623#258603.6.4561#248613.6.5623#2633.6.662623#2503.6.763644654.14.1.166674.1.268694.1.3704.1.471724.1.5734.1.6744.24.2.1754.2.27677784.3 Literaturverzeichnis7980818283848586878889909192 Abkürzungsverzeichnis9394 ERKLÄRUNG AN EIDES STATT95deInhaltsverzeichnisHilfe Literaturverzeichnis Adams, J. M., Cory S. (1998) . The Bcl-2 protein familiy: arbiters of cell survival. Science 281, 1322-26. Adams, P. D., Kaelin W. G. Jr. (1996) . The cellular effects of E2F overexpression . Curr Top Microbiol Immunol 208, 79-93 Altman, D. G., Lausen, B., Sauerbrei, W. et al. (1994) . Dangers of using "optimal" cutpoints in the evaluation of prognostic factors . J Natl Cancer Inst 86, 829-35. Andre, T., Boni, C., Mounedji-Boudiaf, L. et al.(2004). Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 350, 23, 2343-51. Arbeitsgemeinschaft Bevölkerungsbezogener Krebsregister in Deutschland (2002). Krebs in Deutschland - Häufigkeiten und Trends . 3. erweiterte, aktualisierte Ausgabe.
Saarbrücken
: Arbeitsgemeinschaft Bevölkerungsbezogener Krebsregister in Deutschland, 28-32. Arbeitsgemeinschaft CAO/AIO/ARO der Deutschen Krebsgesellschaft ( 1999 ). Aktualisierter Konsensus der CAO/AIO/ARO zur adjuvanten Therapie bei Kolon- und Rektumkarzinom . Onkologie, 22 , 154-56 . Bargou R. C., Wagener C., Bommert K. et al. (1996). Overexpression of the death-promoting gene bax-alpha which is downregulated in breast cancer restores sensitivity to different apoptotic stimuli and reduces tumor growth in SCID mice. J Clin Invest 97, 2651-59. Boland, D., Thibodeau, S., Hamilton, S. et al.(1998). A National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: Development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58: 5248-57. Borresen-Dale, A. L., Lothe, R. A., Meling, G. I. et al. (1998) . TP53 and long-term prognosis in colorectal cancer: Mutations in the L3 zinc-binding domain predict poor survival. Clin Cancer Res 4, 203-210. Bos, J. L. (1989). ras oncogenes in human cancer: a review . Cancer Res 49, 4682-89. Bosanquet A. G., Sturm I., Wieder T. et al. (2002) . Bax expression correlates with cellu lar drug sensitivity to doxorubicin, cyclophosphamid and chlorambucil but not fludarabine, cladribine or corticosteroids in B cell chronic lymphocytic leukemia. Leukemia 16, 1035-44. Bosari, S., Viale, G. (1995) . The clinical significance of p53 aberrations in human tumors. Virchows Arch 427, 229-41. Bosari, S., Viale, G., Bossi, P. (1994). Cytoplasmic accumulation of p53 Protein: an independent prognostic indicator in colorectal adenocarcinomas. J Natl Cancer Inst 86, 681-87. Carton, P. F., Oliver, L., Martin, S. et al. (2002). The expression of a new variant of pro-apoptotic molecule Bax, Baxpsi, is correlated with an increased survival of glioblastoma multiforme patients . Hum Mol Genet 11, 6, 675-87. Chang C., Simmsons D. T., Martin M. A. et al. (1979) . Identification and partial characterization of new antigens from simian virus 40-transformed mouse cells. J Virol 31, 463-71. Cohen, A. M., Minsky, M. B., Schilsky, R. L. (1997) . Cancer of the Colon . In: Cancer. Principles and Practice of Oncology. DeVita, V. T. Jr., Hellmann, S, Rosenberg, S. A.
Philadelphia
: Lippincott-Raven, 1144-1186. Condie, A. (1993) . Detection of point mutations in the p53 gene: comparison of SSCP, constant denaturating gel electrophoresis and hydroxylamine and osmium tetroxide techniques. Hum Mutat 2, 58-66. Cory, S., Vaux, D. L., Strasser, A. et al. (1999) . Insights from Bcl-2 and Myc: malignancy involves abrogation of apoptosis as well as sustained proliferation. Cancer Res 59, 1685-92. Crompton, M. (2000) . Bax, Bid and the permeabilization of the mitochondrial outer membrane in apoptosis. Curr Opin Cell Biol 12, 414-19. Daniel, P. T. (2000) . Dissecting the pathways to death. Leukemia 14, 2035-44. Daniel, P. T. (2003a ). Zellzyklus und Apoptose. In: Molekularmedizinische Grundlagen von hämatologischen Neoplasien. Ganten, Ruckpaul.
Heidelberg
: Springer-Verlag, 130-174. Daniel, P. T., Kroidl, A., Kopp, J., et al. (1998) . Immunotherapy of B-cell lymphoma with CD3x19 bispecific antibodies: costimulation via CD28 prevents "veto" apoptosis of antibody-targeted cytotoxic T cells . Blood 92, 4750-7. Daniel, P. T., Schulze-Osthoff, K., Belka, C. et al. (2003b ). Guardians of cell death: the Bcl-2 family proteins . Essays Biochem , 39 , 73-88. Daniel, P. T., Wieder, T., Sturm, I. et al. (2001) . The kiss of death: Promises and failures of death receptors and ligands in cancer therapy. Leukemia 15, 1022-32. DeAngelis, P. M., Stokke, T., Thorstensen, L. et al (1998). Apoptosis and expressionof Bax, Bcl-x, and Bcl-2apoptotic regulatory proteins in colorectal carcinomas, and associations with p53 geontype/phenotype. J Clin Pathol: MolPathol 51 , 254-61. Elsaleh, H., Powell, B., Soontrapornchai, P. et al. (2000) . p53 gene mutation, microsatellite instability and adjuvant chemotherapy: impact on survival of 338 patientswith Dukes´ C colon carcinoma. Oncology 58, 52-9. Eskes, R., Desagher, S., Antonsson, B. et al. (2000 ): Bid induces the oligomerization and insertion of Bax into the outer mitochondrial membrane . Mol Cell Biol 20 , 929-35. Evan, G. I., Vousden, K. H. (2001) . Proliferation, cell cycle and apoptosis in cancer. Nature 441, 342-48. Evan, G. I., Wyllie, A. H. Gilbert, C. S. et al. (1992) . Induction of apoptosis in fibroblasts by c-myc protein. Cell 69, 119-28. Fearon, E. R., Vogelstein, B. (1990) . A genetic model for colorectal tumorigenesis. Cell 61, 759-67. Fizzotti, M., Cimino, G., Pisegna, S. et al. (1995) . Detection of homozygous deletions of the cyclin-dependent kinase 4 inhibitor (p16) gene in acute lymphoblastic leukemia and association with adverse prognostic features. Blood 85, 2685-90. Foster, B. A., Coffey, H. A., Morin, M. J. et al. (1999) . Pharmacological rescue of mutant p53 conformation and function. Science 286, 2507-10. Frank, S., Gaume, B., Bergmann-Leitner, E. S. et al. (2001). The role of dynamin-related protein I, a mediator of mitochondrial fission, in apoptosis. Dev Cell 1, 515-25. Friedrich K., Wieder T., Haefen C von et al. (2001) . Overexpression of caspase-3 re stores sensitivity for drug-induced apoptosis in breast cancer cell lines with aquired drug resistance. Oncogene 20, 2749-60. Friess, H., Lu, Z., Graber, H. U. et al. (1998) . Bax, but not bcl-2, influences the prognosis of human pancreatic cancer. Gut 43, 414-421. Funk, F. O. (1999) . Cancer cell cycle control. Anticancer Res 19, 4772-80. Gascoyne, R. D., Krajewska, M., Krajewsky, S. et al. (1997) . Prognostic significance of BAX protein expression in diffuse aggressive Non-Hodgkin´s lymphoma. Blood 90, 3173-3178. Geradts, J., Kratzke, R. A., Niehans, G. A. et al. (1995) . Immunohistochemical detection of the cyclin-dependent kinase inhibitor 2/multiple tumor suppressor gene 1 (CDKN2/MTS1) product p16INK4A in archival human solid tumors: correlation with retinoblastoma protein expression. Cancer Res 55, 6006-11. Gillet, C. E., Barnes, D. M. (1998) . Demystified... Mol Pathol 51, 310-16. Gillissen, B., Essmann, F., Graupner, V. et al . (2003) . Induction of cell death by the BH3-only Bcl-2 homolog Nbk/Bik is mediated by an entirely Bax-dependent mitochondrial pathway. EMBO J 22, 14, 3580-90. Glantz S. A. (1998) . Wie man Überlebenszeiten analysiert . In: Biotstatistik: Ein Fach für die Praxis. Hrsg. der dt. Ausg.: Achim Heinecke, Wolfgang Köpcke . McGraw-Hill:
Frankfurt/M
150-75. Goh, H. S., Yao, J., Smith, D. R. (1995) . p53 point mutation and survival in colorectal cancer patients. Cancer Res 55, 5217-21. Goldstein, A. M., Fraser, M. C., Struewing, J. P. (1995) . Increased risk of pancreatic cancer in melanoma-prone kindreds with p16INK4a mutations. N Engl J Med 333, 970-74. Grabowski, P., Mann, B., Mansmann, U. et al. (2000) . Expression of SIALYL-Le(x) antigen defined by MAb AM-3 is an independent prognostic marker in colorectal carcinoma patients. Int J Cancer 88, 281-6. Grabowski, P.,Schindler, I., Anagnostopoulos, I. et al. (2001) . Neuroendocrine differentiation is a relevant prognostic factor in stage III-IV colorectal cancer. Eur Jour Gastroent Hepatol 13, 405-11. Grana, X.,Garriga, J., Mayol, X. (1998) . Role of the retinoblastoma protein family, pRB, p107, and p130 in the negative control of cell growth. Oncogene 17, 3365-83. Greene, F. L. (2003). A new TNM-staging strategy for node-positive (stage III) rectal cancer: An analysis of 5.988 patients . ASCO Annunal Meeting. Gastrointestinal Cancer. Colorectal Cancer Malignancies . www.asco.org . Gronbaek, K., Nully Brown, P de, Moller, M. B. et al. (2000) . Concurrent disruption of p16INK4a and the ARF-p53 pathway predicts poor prognosis in aggressive non-Hodgkin´s lymphoma. Leukemia 14, 1727-35. Gross, A., McDonnell, J. M., and Korsmeyer, S. J. (1999) . BCL-2 family members and the mitochondria in apoptosis. Genes Dev 13, 1899-911. Güner, D., Sturm, I., Hemmati, P. G. et al. (2003) . Multigene analysis of Rb-pathway and apoptosis-control in esophageal squamous cell carcinoma identifies patients with good prognosis. Int J Cancer 103, 445-54. Hamelin, R., Laurent, P. P., Olschwang, S. et al. (1994) . Association of p53 mutations with short survival in colorectal cancer. Gastroenterology 106, 42-8. Hasegawa, H., Ueda, M., Furukawa, K. et al. (1995) . p53 gene mutations in early colorectal carcinoma. De novo vs. adenoma-carcinoma sequence. Int J Cancer 64, 47-51. Hayashi, K., Yandell, D. W. (1998) . How sensitive is PCR-SSCP? Hum Mutat 2, 338-46. Hemmati, P. G., Gillissen, B., von Haefen, C. et al. (2002) . Adenovirus-mediated overexpression of p14ARF induces p53 and bax-independent apoptosis. Oncogene 21, 3149-61. Hermanek, P. (1997) . Prognostische Faktoren beim kolorektalen Karzinom. Zentralbl Chir 122, 20-25. Hermanek, P., Mansmann, U., Staimmer, D. S. et al. (2000) . The German experience. the surgeon as a prognostic factor in colon and rectal cancer surgery . Surg Oncol Clin N Am 9, 33-49. Hermanek, P., Wiebelt, H., Staimmer, D. (1995 ). Expierience of the German multicenter study group SGCRC. Tumori Suppl 81 , 60-4 . Hermann, S., Sturm, I., Mrozek, A. et al. (2001) . BAX expression in benign and malig nant thyroid tumors: Dysregulation of wild type p53 is associated with a high BAX and p21 expression in thyroid carcinoma. Int J Cancer 92, 8 , 805-11 . Heyman, M., Rasool, O., Borgonovo Brandter, L. et al. (1996) . Prognostic importance of p15INK4B and p16INK4 gene inactivation in childhood acute lymphocytic leukemia. J Clin Oncol 14, 1512-20. Hollstein, M., Rice, K., Greenblatt, M. S. et al. (1994) . Database of p53 gene somatic mutations in human tumors and cell lines. Nucleic Acids Res 22, 3551-5. Houlston, R. S., Collins, A., Slack, J et al. (1992). Dominant genes for colorectal cancer are not rare. Ann Hum Genet 56, 99-103. Hsu, Y. T., Youle, R. J. (1998). Bax in murine thymus is a soluble monomeric protein that displays differential detergent-induced conformations. J Biol Chem 273, 10777-83. Hu, Y. X., Watanabe, H., Ohtsubo, K. et al. (1997) . Frequent loss of p16 expression and its correlation with clinicopathological parameters in pancreatic carcinoma. Clin Cancer Res 3, 1473-77. Huang, C. I., Taki, T., Higashiyama, M. et al. (2000). p16 protein expression is associated with a poor prognosis in squamous cell carcinoma of the lung. Br J Cancer 82, 374-80. Hussussian, C. J., Struewing, J. P., Goldstein, A. M. (1994) . Germline p16 mutations in familial melanoma. Nat Genet 8, 15-21. Inohara, N., Ding, L., Chen, S. et al. (1997) . Harakiri, a novel regualator of cell death, encodes a protein that activates apoptosis and interacts selectively with survival-promoting proteins Bcl-2 and Bcl-X(L). EMBO J 16, 1686-94. Johnson, D. G., Walker, C. L. (1999) . Cyclins and cell cycle checkpoints. Annu Rev Pharmacol Toxicol 39, 295-312. Jürgensmeier, J. M., Xie, Z. H., Deveraux, Q. et al. (1998) . Bax directly induces release of cytochrome c from isolated mitochondria. Proc Nat Acad Sci USA 95, 4997-5002. Kannan, K., Kaminski, N., Rechavi, G. et al. (2001) . DNA microarray analysis of genes involved in p53 mediated apoptosis: activation of APAF-1. Oncogene 20, 3449- 55. Kinzler, K. W., Nilbert, M. C., Vogelstein, B. et al. (1991) . Identification of a gene located at chromosome 5q21 that is mutated in colorectal cancers. Science 253, 661-665. Kinzler, K. W., Vogelstein, B. ( 1996 ). Lessons from hereditary colorectal cancer . Cell 87 , 159-70 . Klasa, R. F., List, A. F., Cheson, B. D. (2001) . Rational approches to design of therapeutics targeting molecular markers. Hematology (Am Soc Hematol Educ Program), 443-62. Krajewski, S., Blomqvist, C., Franssila, K. et al. (1995) . Reduced expression of proapoptotic gene BAX is associated with poor response rates to combination chemotherapy and shorter survival in women with metastatic breast adenocarcinoma. Cancer Res 55, 4471-8. Krammer, P. H. (2000) . CD95´s deadly mission in the immune system. Nature 407, 789-95. Kratzke, R. A., Greatens, T. M., Rubins, J. B. et al. (1996) . Rb and p16INK4a expression in resected non-small cell lung tumors. Cancer Res 56, 3415-20. Kress, M., May, E., Cassingena, R. et al. (1979) . Simian virus 40-transformed cells express new species of proteins precitable by simian virus 40 serum. J virol 31, 472-83. Kroemer, G. J., Reed, C. (2000) . Mitochondrial control of cell death . Nat Med 6, 523-19. Laken, S. J., Petersen, G. M., Gruber, S. B. et al.(1997). Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC. Nature Genet 17, 79-83. Lane, D. P., Crawford, L. V. (1979). T antigen is bound to a host protein in SV40-transformed cells. Nature 278, 261-263. Lauber, K., Bohn, E., Kröber, S. M. et al. (2003). Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of lipid attraction signal. Cell 113, 717-30. Li, A. J., Blow, J. (2001) . The origin of CDK regulation. Nat Cell Biol 3, E182-84. Li, P., Nijhawan, D., Budihardjo, I. et al. (1997) . Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91, 479-89. Liang, J., Chang, K., Chen, J. et al. (1999) . Hypermethylation of the p16 gene in sporadic T3 N0 M0 stage colorectal cancer: association with DNA replication error and shorter survival. Oncology 57, 149-56. Linzer, D. I. H., Levine, A. J. (1979) . Characterization of a 54 KDa cellular tumorantigen present in SV40-transformed cells and in infected embryonal carcinoma cells. Cell 1, 43-52. Lorenz, M., Mueller, H. H., Mattes, E. et al. ( 2001 ). Phase II study of weekly 24-hour intra-arterial high-dose infusion of 5-fluorouracil and folinic acid for liver metastases from colorectal cancer. Ann Oncol 12 , 3 , 321-5. Lorenz, M., Staib-Sebler, E., Gog, C. et al. (2003). Prospective pilot study of neoadjuvant chemotherapy with 5-fluorouracil, folinic acid and oxaliplatin in resectable liver metastases of colorectal cancer. Analysis of 42 neoadjuvant chemotherapies. Zentralbl Chir 128, 2, 87-94. Lowry, D. R., Willumsen, B. M. (1993). Function and regulation of ras . Ann Rev Biochem 62, 851-91. Luo, X., Budihardjo, I., Zou, H. et al. (1998) . Bid, a Bcl-2 interacting protein, mediates cytochrom c release from mitochondria in response to activation of cell surface death receptors. Cell 94, 481-90. Maaser, K., Hopfner, M., Jansen, A. et al. (2001) . Specific ligands of the peripheral benzodiazepine receptor induce apoptosis and cell cycle arrest in human colorectal cancer cells. Br J Cancer 85, 1771-80. Marks, J. R., Davidoff, A. M., Kerns, B. J. et al.(1991). Overexpression and mutations in epithelial ovarian cancer. Cancer Res 51, 2979-84. Martinou, J. C., Green, D. R. (2001) . Breaking the mitochondrial barrier. Nat Rev Mol Cell Biol 2, 63-67. Müller-Tidow, C., Metzelder, S. K., Buerger, H. (2004). Expression of the p14(ARF) tumor suppressor predicts survival in acute myeloid leukemia. Leukemia. Epub ahead of print. McCurrach, M. E., Connor, T. M., Knudson, C. M. (1997) . Bax-deficiency promotes drug resistance and oncogenic transformation by attenuating p53-dependent apoptosis. Proc Natl Acad Sci U S A 94, 2345-9. Meijerink, J. P., Mensink, E. J., Wang, K. et al. (1998) . Hematopoetic malignancies demonstrate loss-of-function mutations of BAX. Blood 91, 8 , 2991-7. Merkel, S., Mansmann, U., Papadopoulos, T. et al. (2001). The prognostic inhomogenity of colorectal carcinomas stage III. a proposal for subdivison of stage III. Cancer 92, 11, 2754-59. Miller, B. A., Gloeckler, L. A., Hankaiy, W. F. et al. (1992 ). Cancer statistics review 1973-89. US Department of Health and Human Services
, Bethesda.
 Miyashita, T., Reed, J. C. (1995) . Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80, 293-9. Miyoshi, Y., Iwao, K., Nagasawa, Y. (1998). Activation of the β -Catenin gene in primary hepatocellular carcinomas by somatic alterations involving exon 3. Cancer Res 58 , 2524-27 . Moertel, C. G., Fleming, T. R., Macdonald, J. S. et al. ( 1995 ). Fluorouracil plus levamisol as effective adjuvant therapy after resection of stage III colon carcinoma: a final report. Ann Intern Med 122, 5 , 321-6 . Morin, P. J. (1999). β -Catenin signalling in cancer. BioEssays 21, 1021-30. Morin, P. J., Vogelstein, B., Kinzler, K. W. (1996 ). Apoptosis and APC in colorectal tumorigenesis. Proc Natl Acad Sci USA 93: 7950-54. Nakano, K., Wousden, K. H. (2001) . PUMA, a novel proapoptotic gene, is induced by p53. Mol Cell 7, 683-94. Newton, C. R., Graham, A. (1994) . PCR .
Heidelberg:
Spektrum Akademischer Verlag, 156-58. Oda, E., Ohki, R., Murasawa, H. et al. (2000) . Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science 288, 1053-58. Ogura, E., Senzaki, H., Yamamoto, D. et al. (1999). Prognostic significance of Bcl-2, Bcl-xL/S, Bax and Bak expressions in colorectal carcinomas. Oncol Reports 6, 365-69. Oltvai, Z. N., Milliman, C. L., and Korsmeyer, S. J. (1993) . Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74, 609-19. Orita, M. (1989) . Rapid and sensitive detection of point mutations and DNA polymorphisms using the PCR. Genomics 5, 874-79. Ozawa, M., Baribault, H., Kemler, R. (1989). The cytoplasmic domain of the cell adhesion molecule uvomorulin associates with three independent proteins structurally related in different species. EMBO J 8, 1711-17. Papadimitrakopoulou, V., Izzo, J., Lippman, S. M. et al. (1997) . Frequent inactivation of p16INK4a in oral premalignant lesions. Oncogene 14, 1799-803. Paradiso, A., Rabinovich, M., Vallejo, C. et al. (1996) . p53 and PCNA expression in advanced colorectal cancer: response to chemotherapy and long-term prognosis. Int J Cancer 69, 437-41. Pastorino, J. G., Chen, S. T., Tafani, M. et al. (1998) . The overexpression of Bax produces cell death upon induction of the mitochondrial permeability transition. J Biol Chem 273, 7770-7775. Poller, D. N., Baxter, K. J., and Shepherd, N. A. (1997) . p53 and Rb1 protein expression: are they prognostically useful in colorectal cancer? Br J Cancer 75, 87-93. Pricolo, V. E., Finkelstein, S. D., Hansen, K. et al. (1997) . Mutated p53 gene is an independent adverse predictor of survival in colon carcinoma. Arch Surg 132, 371-4. Prokop, A., Wieder, T., Sturm, I. et al. (2000) . Relapse of childhood acute lymphoblastic leukemia is associtated with a decrease of the bax/bcl-2 ratio and loss of spontaneous caspase-3 processing in vivo. Leukemia 14, 1606-13. Radetzki, S., Kohne, C. H., von Haefen, C. et al. (2002) . The apoptosis promoting bcl-2 homologs nbk/bik overcome drug resistance in mdr-1-negative and mdr-1-overexpressing breast cancer cell lines. Oncogene 20, 227-38. Rampino, N., Yamamoto, H., Ionov, Y. et al. (1997). Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science 275, 967-9. Rao, R. V., Hermel, E., Castro-Obregon, S. et al. (2001) . Coupling endoplasmic reticu lum stress to the cell death program. Mechanism of caspase activation . J Biol Chem 276, 33869-74. Rau, B., Sturm, I., Lage, H. et al. (2003) . Dynamic Expression Profile of 21WAF/CIP1 and Ki-67 predicts survival in rectal carcinoma treted with preoperative radiochemotherapy. J Clin Oncol 21, 3391-3401. Reed, J. A., Loganzo, F., Jr., Shea, C. R. et al. (1995) . Loss of expression of the p16/cyclin-dependent kinase inhibitor 2 tumor suppressor gene in melanocytic lesions correlates with invasive stage of tumor progression. Cancer Res 55, 2713-8. Reed, J. C., Miyashita, T., Takayama, S. et al. (1996) . Bcl-2 family proteins: regulators of cell death involved in the pathogenesis of cancer and resistance to therapy. J Cell Biochem 60, 23-32. Robbins, P. F., El-Gamil, M., Li, Y. F. (1996). A mutated β -catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes . J Exp Med 183 , 1185-92. Rodrigues, N. R., Rowan, A., Smith, M. E. et al. (1990). p53 mutations in colorectal cancer. Proc Natl Acad Sci USA 87, 7555-59. Roussel, M. F. (1999) . The INK4a family of cell cycle inhibitors in cancer. Oncogene 18, 5311-17. Rozenfeld-Granot, G., Toren, A., Amariglio, N. et al. (2001) . Mutation analysis of the FAS and TNFR apoptotic cascade genes in hematological malignancies. Exp Hematol 29, 399-402. Ruas, M., Peters, G. (1998) . The p16INK4a/CDKN2A tumor suppressor and its relatives. Biochim Biophys Acta 1378, F115-77. Rudner, J., Jendrossek, V., Belka, C. (2002). New insights in the role of Bcl-2 Bcl-2 and the endoplasmatic reticulum. Apoptosis, 7, 5, 441-7. Sandig, V., Brand, K., Herwig, S. et al. (1997) . Adenovirally transferred p16INK4/ CDKN2 and p53 genes cooperate to induce apoptotic tumor cell death. Nat Med 3, 313-9. Schmitt, C, A., McCurrach, M. E., Stanchina, E. de et al. (1999) . INK4a/ARF mutations accelerate lymphomagenesis and promote chemoresistance by diabling p53. Genes Dev 13, 2670-2677. Schmoll, H. J. (1997). Kolorektales Karzinom. In: Kompendium Internistische Onkologie. Schmoll, H. J., Höffken, K., Possinger, K.
Heidelberg
: Springer Verlag, 694-759. Senderowicz, A. M. (2000) . Small molecule modulators of cyclin-dependent kinases for cancer therapy. Oncogene 19, 6600-6606. Serrano, M., Lin, A. W., McCurrach, M. E. et al. (1997) . Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88, 593-602. Shapiro, G. I., Edwards, C. D., Ewen, M. E. et al. (1998) . p16INK4A participates in a G1 arrest checkpoint in response to DNA damage. Mol Cell Biol 18, 378-87. Sharpless, N. E., DePinho, R. A. (1999) . The INK4a/ARF locus and its two gene products. Curr Opin Genet Dev 9, 22-30. Shimizu, S., Ide, T., Yanagida, T. et al. (2000) . Electrophysiological study of a novel large pore formed by Bax and the voltage-dependent anion channel that is permeable to cytochrome c. J Biol Chem 275, 12321-25 . Simms, L. A., Radford-Smith, G., Biden, K. G. et al. (1998). Reciprocal Relationship between the tumor suppressors p53 and BAX in primary colorectal cancer. Oncogene, 17 , 15 , 2003-8. Soengas, M. S., Capodieci, P., Polsky, D. et al. (2001). Inactivation of the apoptosis effector Apaf-1 in malignant melanoma. Nature 409, 207-11. Soong, R., Powell, B., Elsaleh, H. et al. (2000) . Prognostic significance of TP53 gene mutation in 995 cases of colorectal carcinoma. Influence of tumor site, stage, adjuvant chemotherapy and type of mutation. Eur J Cancer 36, 2055-60. Soong, R., Robbins, P. D., Dix, B. R. et al. (1996) . Concordance between p53 protein overexpression and gene mutation in a large series of common human carcinomas. Hum Pathol 27, 1050-5. Sturm, I., Bosanquet, A., Head, D. (2003) . P53 mutation in B-CLL: Impact on drug sensitivity profiles and disease prognosis. Cell Death Diff 10, 477-84. Sturm, I., Kohne, C. H., Wolff, G. et al. (1999) . Analysis of the p53/BAX pathway in colo rectal cancer: low BAX is a negative prognostic factor in patients with resected liver metastases. J Clin Oncol 17, 1364-74. Sturm, I., Papadopoulos, S., Hillebrand, T. et al. (2000) . Impaired BAX protein expression in breast cancer: mutational analysis of the BAX and the p53 gene. Int J Cancer 87, 517-21. Sturm, I., Petrowsky, H., Volz, R. et al. (2001) . Analysis of p53/BAX/p16INK4a/CDKN2 in esophageal squamous cell carcinoma: High BAX and p16INK4a/CDKN2 identifies patients with good prognosis. J Clin Oncol, 19, 8, 2272-81. Sugarbaker, J. P., Gunderson, L. L., Wittes, R. E. (1985). Colorectal cancer . Cancer: Principles and practices of oncology. DeVita, V. T., Hellmann, S., Rosenberg, S. A.
Philadelphia: J. B.
Lippincott 800-3. Tai, Y. T., Lee, S., Niloff, E. et al. (1998) . BAX protein expression and clinical outcome in epithelial ovarian cancer. J Clin Oncol 16, 2583-90. Taylor, W. R., Stark, G. R. (2001) . Regulation of the G2/M transition by p53. Oncogene 20, 1803-15. Tournigand, C., Andre, T., Achille, E. et al.(2004). FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. J Clin Oncol 22, 2, 229-37. van Loo, G., Saelens, X., van Gurp, M. et al. (2002). The role of mitochondrial factors in apoptosis: a russian roulette with more than one bullet . Cell Death Diff 9, 1031-42. Violette, S., Poulain, L., Dussaulx, E. et al. (2002) . Resistance of colon cancer cells to long-term 5-fluorouracil exposure is correlated to the realtive level of Bcl-2 and Bcl-X(L) in addition to the Bax and p53 status . Int J Cancer 98, 4 , 498-504. Vogelstein, B., Fearon, E. R., Hamilton, S. R. (1988). Genetic alterations during colorectal-tumor development. N Engl J Med 319, 9, 527-32. Wagener, C., Bargou, R. C., Daniel, P. T. et al. (1996) . Induction of the death-promoting gene bax-alpha sensitizes cultured breast-cancer cells to drug-induced apoptosis. Int J Cancer 67, 138-41. Waldman, T., Lengauer, C., Kinzler, K. W. et al. (1996) . Uncoupling of S phase and S phase and mitosis induced by anticancer agents in cells lacking p21. Nature 381, 713-16. Wang, K., Yin, X. M., Chao, D. T. et al. (1996) . Bid: a novel BH3 domain-only death agonist. Genes Dev 10, 2859-69. Weissburger, J. H., Wynder, E. L. (1987). Etiology of colorectal cancer with emphasis on mechanism of action and prevention. Important advances in oncology. DeVita, V. T., Hellmann, S., Rosenberg, S. A.
Philadelphia
: J. B. Lippincott, 197. Weyrer, K., Feichtinger, H., Haun, M. et al. (1996) . p53, Ki-ras, and DNA ploidy in human pancreatic ductal adenocarcinomas. Lab Invest 74, 279-89. Wieder, T., Essmann, F., Prokop, A. et al. (2001) . Activation of caspase-8 in drug-induced apoptosis of B-lymphoid cells is independent of CD95/Fas receptor-ligand interaction and occurs downstream of caspase-3 . Blood 97, 5 , 1378-87. Wu, G. S., El-Deiry, W. S. (1996) . Apoptotic death of tumor cells correlates with chemosensitivity, independent of p53 or bcl-2. Clin Cancer Res 2, 623-33. Xiong, Y., Hannon, G. J., Zhang, H. et al. (1993) . p21 is a universal inhibitor of cyclin dependent kinases. Nature 366, 6456 , 701-4. Yang, J., Liu, X., Bhalla, K. (1997) . Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275, 1129-32 . Zeng, Z. S., Sarkis, A. S., Zhang, Z. F. et al. (1994). p53 nuclear overexpression: an independent predictor of survival in lymphnode positive colorectal cancer patients. J Clin Oncol 12, 10, 2043-50.